Search

everythinglearnresearchcommunity

for

Search:↓

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.

A postmenopausal woman's hormone imbalance and symptoms improved after removing benign ovarian tumors.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

A holistic approach, including diet and stress management, may improve androgenetic alopecia treatment outcomes.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

TA-Ado effectively promotes hair growth and reduces hair loss.

Ayurveda-based care may improve quality of life for breast cancer patients without serious side effects.

Removing the ovarian tumor improved the woman's hormonal symptoms.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

Most patients experienced significant but reversible hair loss during treatment.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Upadacitinib may effectively treat alopecia areata without side effects.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.